Daewoong Co., Ltd. (KRX:003090)
21,500
+150 (0.70%)
At close: Jan 9, 2026
Daewoong Market Cap
Daewoong has a market cap or net worth of 879.15 billion as of January 9, 2026. Its market cap has increased by 4.88% in one year.
Market Cap
879.15B
Enterprise Value
1.95T
Revenue
2.06T
Ranking
n/a
PE Ratio
11.34
Stock Price
21,500.00
Market Cap Chart
Since July 9, 1993, Daewoong's market cap has increased from 29.92B to 879.15B, an increase of 2,838.50%. That is a compound annual growth rate of 10.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 879.15B | -2.49% |
| Dec 30, 2025 | 901.64B | 2.08% |
| Dec 30, 2024 | 883.24B | 4.38% |
| Dec 28, 2023 | 846.16B | - |
| Dec 29, 2022 | 846.18B | -34.43% |
| Dec 30, 2021 | 1.29T | -38.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.93T |
| Celltrion | 47.48T |
| ALTEOGEN | 25.59T |
| ABL Bio | 11.88T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.46T |
| HLB Co., Ltd. | 6.66T |
| LigaChem Biosciences | 6.62T |